The Impact of Vitamin B12 Supplementation on Clinical Outcomes in Patients With Diabetic Neuropathy: A Meta-Analysis of Randomized Controlled Trials

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2022 Dec 2

PMID 36457818

Authors

Jithin Karedath

Saima Batool

Abia Arshad

Sumon Khalique

Sooraj Raja

Bihari Lal

Venkata Anirudh Chunchu

Shamsha Hirani

Affiliations

Soon will be listed here.

Abstract

Diabetic neuropathy (DN) is one of the most prevalent and expensive microvascular consequences of diabetes mellitus (DM), which is noteworthy given that it is frequently both underdiagnosed and undertreated in daily clinical practice. The aim of the current article was to review the efficiency of vitamin B12 supplementation in isolation or in combination therapy for the treatment of diabetic peripheral neuropathy. This meta-analysis was designed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). A systematic electronic search was performed in PubMed and Cochrane Library to identify randomized controlled trials (RCTs) assessing the impact of vitamin B12 outcomes in patients with diabetic neuropathy without putting restrictions on the year of publication. A combination of the following keywords was used: "diabetic neuropathy," "vitamin B12," and "outcomes." The primary outcomes assessed in the current meta-analysis included neuropathic symptoms and vibration perception threshold (VPT). Secondary outcomes included a change in pain score from baseline, total cholesterol (mg/dL), high-density lipoprotein (HDL), and low-density lipoprotein (LDL). A total of six articles were selected to be included in the current meta-analysis. Patients receiving vitamin B12 showed a greater reduction of mean neuropathic symptoms (standardized mean difference (SMD): -0.39, 95% confidence interval (CI): -0.73, -0.05, p-value: 0.03) and pain score (SMD: -3.60, 95% CI: -4.68, -1.43, p-value<0.001) compared to the control group. No significant effect of vitamin B12 was found on VPT (mean difference (MD): -4.80, 95% CI: -11.03, 1.42, p-value: 0.13), change in HDL (MD: 0.14, 95% CI: -2.37, 2.65, p-value: 0.91), LDL (MD: 2.59, 95% CI: -5.94, 11.12, p-value: 0.55), and total cholesterol (MD: -2.72, 95% CI: -11.52, 6.08, p-value: 0.54). The current meta-analysis found that vitamin B12 can improve neuropathic symptoms and reduce pain in patients with diabetic neuropathy. However, the current study did not report any significant difference between patients who received vitamin B12 and placebo in terms of HDL, LDL, and total cholesterol.

Citing Articles

Clinical Pathobiochemistry of Vitamin B Deficiency: Improving Our Understanding by Exploring Novel Mechanisms with a Focus on Diabetic Neuropathy.

Schleicher E, Didangelos T, Kotzakioulafi E, Cegan A, Peter A, Kantartzis K Nutrients. 2023; 15(11).

PMID: 37299560 PMC: 10255445. DOI: 10.3390/nu15112597.

References

Ishibashi F, Taniguchi M, Kosaka A, Uetake H, Tavakoli M . Improvement in Neuropathy Outcomes With Normalizing HbA in Patients With Type 2 Diabetes. Diabetes Care. 2018; 42(1):110-118. DOI: 10.2337/dc18-1560. View

Wang J, Wu Y, Liu S, Lin Y, Lu P . Vitamin B12 for herpetic neuralgia: A meta-analysis of randomised controlled trials. Complement Ther Med. 2018; 41:277-282. DOI: 10.1016/j.ctim.2018.10.014. View

Fonseca V, Lavery L, Thethi T, Daoud Y, Desouza C, Ovalle F . Metanx in type 2 diabetes with peripheral neuropathy: a randomized trial. Am J Med. 2012; 126(2):141-9. DOI: 10.1016/j.amjmed.2012.06.022. View

Li S, Chen X, Li Q, Du J, Liu Z, Peng Y . Effects of acetyl-L-carnitine and methylcobalamin for diabetic peripheral neuropathy: A multicenter, randomized, double-blind, controlled trial. J Diabetes Investig. 2016; 7(5):777-85. PMC: 5009142. DOI: 10.1111/jdi.12493. View

Aroda V, Edelstein S, Goldberg R, Knowler W, Marcovina S, Orchard T . Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study. J Clin Endocrinol Metab. 2016; 101(4):1754-61. PMC: 4880159. DOI: 10.1210/jc.2015-3754. View

Jurna I . [Analgesic and analgesia-potentiating action of B vitamins]. Schmerz. 2003; 12(2):136-41. DOI: 10.1007/s004829800054. View

Jayabalan B, Low L . Vitamin B supplementation for diabetic peripheral neuropathy. Singapore Med J. 2016; 57(2):55-9. PMC: 4759374. DOI: 10.11622/smedj.2016027. View

Bennett G . Update on the neurophysiology of pain transmission and modulation: focus on the NMDA-receptor. J Pain Symptom Manage. 2000; 19(1 Suppl):S2-6. DOI: 10.1016/s0885-3924(99)00120-7. View

Tesfaye S, Boulton A, Dyck P, Freeman R, Horowitz M, Kempler P . Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010; 33(10):2285-93. PMC: 2945176. DOI: 10.2337/dc10-1303. View

10.

Boulton A, Vinik A, Arezzo J, Bril V, Feldman E, Freeman R . Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. 2005; 28(4):956-62. DOI: 10.2337/diacare.28.4.956. View

11.

Ting R, Szeto C, Chan M, Ma K, Chow K . Risk factors of vitamin B(12) deficiency in patients receiving metformin. Arch Intern Med. 2006; 166(18):1975-9. DOI: 10.1001/archinte.166.18.1975. View

12.

Andres E, Henoun Loukili N, Noel E, Maloisel F, Vinzio S, Kaltenbach G . Effects of oral crystalline cyanocobalamin 1000 μg/d in the treatment of pernicious anemia: An open-label, prospective study in Ten Patients. Curr Ther Res Clin Exp. 2014; 66(1):13-22. PMC: 3964566. DOI: 10.1016/j.curtheres.2005.02.001. View

13.

Didangelos T, Doupis J, Veves A . Painful diabetic neuropathy: clinical aspects. Handb Clin Neurol. 2014; 126:53-61. DOI: 10.1016/B978-0-444-53480-4.00005-9. View

14.

Farvid M, Homayouni F, Amiri Z, Adelmanesh F . Improving neuropathy scores in type 2 diabetic patients using micronutrients supplementation. Diabetes Res Clin Pract. 2011; 93(1):86-94. DOI: 10.1016/j.diabres.2011.03.016. View

15.

Solomon L . Diabetes as a cause of clinically significant functional cobalamin deficiency. Diabetes Care. 2011; 34(5):1077-80. PMC: 3114505. DOI: 10.2337/dc11-0009. View

16.

Didangelos T, Karlafti E, Kotzakioulafi E, Margariti E, Giannoulaki P, Batanis G . Vitamin B12 Supplementation in Diabetic Neuropathy: A 1-Year, Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients. 2021; 13(2). PMC: 7912007. DOI: 10.3390/nu13020395. View

17.

Russell J, Zilliox L . Diabetic neuropathies. Continuum (Minneap Minn). 2014; 20:1226-40. PMC: 4208099. DOI: 10.1212/01.CON.0000455884.29545.d2. View

18.

Beulens J, Hart H, Kuijs R, Kooijman-Buiting A, Rutten G . Influence of duration and dose of metformin on cobalamin deficiency in type 2 diabetes patients using metformin. Acta Diabetol. 2014; 52(1):47-53. DOI: 10.1007/s00592-014-0597-8. View

19.

Stracke H, Lindemann A, Federlin K . A benfotiamine-vitamin B combination in treatment of diabetic polyneuropathy. Exp Clin Endocrinol Diabetes. 1996; 104(4):311-6. DOI: 10.1055/s-0029-1211460. View

20.

Hansen C, Jensen J, Ridderstrale M, Vistisen D, Jorgensen M, Fleischer J . Vitamin B12 deficiency is associated with cardiovascular autonomic neuropathy in patients with type 2 diabetes. J Diabetes Complications. 2016; 31(1):202-208. DOI: 10.1016/j.jdiacomp.2016.08.025. View